DaVita SG&A Expenses 2010-2024 | DVA

DaVita annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • DaVita sg&a expenses for the quarter ending September 30, 2024 were $0.394B, a 4.42% increase year-over-year.
  • DaVita sg&a expenses for the twelve months ending September 30, 2024 were $1.525B, a 5.03% increase year-over-year.
  • DaVita annual sg&a expenses for 2023 were $1.474B, a 8.77% increase from 2022.
  • DaVita annual sg&a expenses for 2022 were $1.355B, a 13.37% increase from 2021.
  • DaVita annual sg&a expenses for 2021 were $1.195B, a 4.19% decline from 2020.
DaVita Annual SG&A Expenses
(Millions of US $)
2023 $1,474
2022 $1,355
2021 $1,195
2020 $1,248
2019 $1,103
2018 $1,135
2017 $1,064
2016 $1,073
2015 $1,031
2014 $1,262
2013 $1,176
2012 $890
2011 $685
2010 $572
2009 $532
DaVita Quarterly SG&A Expenses
(Millions of US $)
2024-09-30 $394
2024-06-30 $368
2024-03-31 $362
2023-12-31 $401
2023-09-30 $377
2023-06-30 $364
2023-03-31 $332
2022-12-31 $380
2022-09-30 $365
2022-06-30 $315
2022-03-31 $295
2021-12-31 $323
2021-09-30 $293
2021-06-30 $298
2021-03-31 $281
2020-12-31 $305
2020-09-30 $363
2020-06-30 $316
2020-03-31 $264
2019-12-31 $278
2019-09-30 $299
2019-06-30 $275
2019-03-31 $251
2018-12-31 $269
2018-09-30 $336
2018-06-30 $264
2018-03-31 $267
2017-12-31 $265
2017-09-30 $273
2017-06-30 $263
2017-03-31 $263
2016-12-31 $-107
2016-09-30 $407
2016-06-30 $387
2016-03-31 $386
2015-12-31 $-12
2015-09-30 $353
2015-06-30 $348
2015-03-31 $342
2014-12-31 $356
2014-09-30 $323
2014-06-30 $299
2014-03-31 $284
2013-12-31 $319
2013-09-30 $305
2013-06-30 $268
2013-03-31 $284
2012-12-31 $274
2012-09-30 $198
2012-06-30 $213
2012-03-31 $205
2011-12-31 $187
2011-09-30 $183
2011-06-30 $164
2011-03-31 $152
2010-12-31 $150
2010-09-30 $148
2010-06-30 $136
2010-03-31 $137
2009-12-31 $137
2009-09-30 $135
2009-06-30 $132
2009-03-31 $127
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.667B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00